Showing 611-620 of 1066 results for "".
- Epilepsy Essentialshttps://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/PN0505Epilepsy-pdf/31451/Epilepsy is often perceived as a condition affecting primarily adolescents and young adults, but its incidence in the elderly is approximately twice that of individuals under 65. With the global population aging, the number of elderly patients with epilepsy is expected to rise significantly. Diagnos
- Epilepsy Essentials: Exploring the Mysterious Link Between Sleep and Epilepsyhttps://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/PN0305Epilepsy-pdf/31479/Sleep plays a crucial role in overall health, occupying about one-third of our lives. In the medical field, particularly among physicians and nurses, sleep deprivation is recognized for its detrimental effects on cognitive functions such as memory, attention, and concentration, which can lead to inc
- Expert Opinionhttps://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/PN0305ExpertOpinion-pdf/31480/Does “Benign” Multiple Sclerosis Really Exist? A Clinical AnalysisIn the March 2005 issue of *Practical Neurology*, Dr. George G. Hutton provides an expert opinion on the existence and diagnosis of benign multiple sclerosis (MS) through the examination of a 53-year-old male patient. The case centers
- Pain Managementhttps://practicalneurology.com/diseases-diagnoses/headache-pain/pn0205pain-management-pdf/31486/A Comprehensive Overview of Three FDA-Approved Chronic Pain MedicationsIn late 2004, the FDA approved three novel medications for chronic pain management: Cymbalta (duloxetine), Lyrica (pregabalin), and Prialt (ziconotide). These advancements offer new avenues for healthcare professionals addressing
- Epilepsy Essentialshttps://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/0105-epilepsy-pdf/31502/Optimal Referral Practices for Refractory Epilepsy CasesDetermining the appropriate timing for referring patients with challenging epilepsy to specialized epilepsy centers remains a topic of debate among neurologists. Referrals may occur early after initial seizure events to confirm diagnoses or uti
Clinical Genetic Testing for Alzheimer Disease and Related Dementias
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/clinical-genetic-testing-for-alzheimer-disease-and-related-dementias/32139/Understanding the role of genetics in neurodegenerative dementia can help guide testing and improve clinical practice.Surgical Management of Epilepsy in Older Adults: Focus on Neurostimulation and Neuromodulation
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/surgical-management-of-epilepsy-in-older-adults-focus-on-neurostimulation-and-neuromodulation/32177/Recent developments in surgical epilepsy, especially minimally invasive procedures and neuromodulatory devices, may be particularly useful in the management of drug-resistant epilepsy in older adults.Blood Tests for Alzheimer Disease
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/blood-tests-for-alzheimer-disease/31731/Blood tests for Alzheimer disease are moving toward clinical implementation and interpretation.MS Minute: Oral Therapies for MS
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/ms-minute-oral-therapies-for-ms/31607/The advent of oral therapies has ushered in a new phase of disease-modifying treatments.- News Briefshttps://practicalneurology.com/columns/practice-management/news-briefs/31327/Thousands of neurologists gathered at the San Diego Convention Center from April 1-8 for the American Academy of Neurology’s (AAN) annual conference, fostering extensive collaboration across subspecialties. Among the key highlights were the release of four new evidence-based practice parameters for